Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
011040
vs
K
KOSPI 200
Over the past 12 months, Kyungdong Pharm has underperformed KOSPI 200, delivering a return of -16% compared to KOSPI 200's +53% growth.
Stocks Performance
011040 vs KOSPI 200
Performance Gap
011040 vs KOSPI 200
Performance By Year
011040 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Kyungdong Pharm
Glance View
Kyungdong Pharm is a South Korean pharmaceutical company that makes and sells medicines for everyday health needs. Its business is centered on branded prescription and over-the-counter drugs, along with some health-related products that are sold through pharmacies and other medical channels. The company’s customers are mainly hospitals, clinics, pharmacies, and consumers who buy medicine for common conditions. The company makes money by producing pharmaceutical products and selling them through distributors and healthcare channels. Like many drug makers, it earns revenue when its products are stocked by pharmacies, prescribed by doctors, or purchased directly by consumers. Its role in the value chain is straightforward: it turns pharmaceutical ingredients and formulations into finished medicines that can be used in the market. What makes this kind of business different is that demand is tied to healthcare needs rather than fashion or consumer trends. Kyungdong Pharm depends on trust in product quality, regulatory approval, and relationships with medical and pharmacy buyers. That gives it a more specialized, regulated business model than a typical consumer goods company.